medigraphic.com
ISSN 2448-8720 (Print)
Organo Oficial de la Secretaria de Salud de Quintana Roo

2019, Number 41

<< Back Next >>

Salud Quintana Roo 2019; 12 (41)

Adherence to antihypertensive drugs in patients from the Village of Punuare, Department of Olancho, Honduras

Díaz-Molina M, Polo-Vega JC, Meza-Solís ME

Language: Spanish
References: 16
Page: 7-12
PDF size: 479.31 Kb.


ABSTRACT

Introduction. Lack of adherence to the therapeutic regimen is common in chronic diseases. In the case of arterial hypertension, the number of non-compliant patients reaches around 40% for pharmacological treatment and between 60-90% for hygienicdietary measures. Non-compliance makes the prescribed treatment ineffective, producing an increase in morbidity and mortality.
Materials and method. A cross-sectional study was conducted to evaluate the adherence with antihypertensive drugs of a sample of patients from the health center of the village of Punuare in the department of Olancho, Honduras. Indirect methods were used such as the Morisky-Green-Levine questionnaire, the Martin- Bayarre-Grau questionnaire, the frequency of drug withdrawal and the measurement of blood pressure values. Kendall’s tau_b coefficient was determined to evaluate the degree of agreement between the different methods used. The variables included in the study were age, gender, type of therapy, pharmacological treatment and adherence.
Results. A predominance of female patients was found, with age ranges of 51-70 years, with predominance of controlled high blood pressure (39%). Enalapril was the most widely used drug (43% of patients). The percentage of adherent patients was 75% according to the Morisky-Green-Levine questionnaire and 41% according to the Martin-Bayerre-Grau questionnaire.
Conclusions. It is necessary to work to raise the levels of therapeutic and non-therapeutic adherence in order to achieve better control of the disease in the patients studied.


REFERENCES

  1. Mancia et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. Journal of Hypertension 2013, 31:1281–1357.

  2. Gijón-Conde T. et al. Documento de la Sociedad Española de Hipertensión- Liga Española para la Lucha contra la Hipertensión Arterial (SEH-LELHA) sobre las guías ACC/AHA 2017 de hipertensión arterial. Hipertens Riesgo Vasc. 2018;35(3):119-129.

  3. Rapsomaniki E, Timmis A, George J, Pujades-Rodriguez M, ShahAD, Denaxas S, et al. Blood pressure and incidence of twelvecardiovascular diseases: Lifetime risks, healthy life-years lost, and age-specific associations in 1.25 million people. Lancet 2014; 383:1899-911.

  4. Martín AL, Bayarre VH, Corugedo RMC, Vento IF, La Rosa MY, Orbay AMC. Adherencia al tratamiento en hipertensos atendidos en áreas de salud de tres provincias cubanas. Revista Cubana de Salud Pública 2015; 41 (1).

  5. Martín L, Sairo M, Bayarre H. Frecuencia de cumplimiento del tratamiento médico en pacientes hipertensos. Rev Cubana Med Gen Integr. [Consultado 23 de enero de 2019] 2003; 19(2). Disponible en: http://www.sld.cu/galerias/ pdf/servicios/hta/frecuencia_de_cumplimiento_tratamiento_medico_en_ pac._hta.pdf.

  6. Orellana D, Chacón K, Quizhpi J, Álvarez M. Estudio Transversal: Prevalencia de Hipertensión Arterial, Falta de Adherencia al Tratamiento Antihipertensivo y Factores Asociados en Pacientes de los Hospitales José Carrasco Arteaga y Vicente Corral Moscoso. Revista Médica HJCA 2016; 8 (3).

  7. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986; 24: 67-74.

  8. Martín AL, Bayarre VH, Grau JA. Validación del cuestionario MBG (Martín- Bayarre-Grau) para evaluar la adherencia terapéutica en hipertensión arterial. Rev Cubana Salud Pública[Internet]. 2008;34(1). Disponible en: http://scielo.sld.cu/scielo.php? script=sci_arttext&pid=S0864- 34662008000100012&lng=es. Mar [consultado 25 de enero de 2019].

  9. López Romero LA, Romero Guevara SL, Parra DI, Rojas Sánchez LZ. Adherencia al tratamiento: Concepto y medición. Hacia promoc. salud. 2016; 21(1): 117-137.

  10. Valencia-Monsalvez F, Mendoza-Parra S, Luengo-Machuca L. Evaluación de la escala Morisky de adherencia a la medicación (MMAS-8) en adultos mayores de un centro de atención primaria en Chile. Rev. Perú. Med. Exp. Salud Publica [Internet]. 2017[Consultado 25 de enero2019];34(2):245-249. Disponible en: http://dx.doi.org/10.17843/rpmesp.2017.342.2206.

  11. Aid Kunert J. Adherencia al tratamiento antihipertensivo Rev. virtual Soc. Parag. Med. Int. setiembre 2015; 2 (2):43-51. Disponible en: http://dx.doi. org/10.18004/rvspmi/2312-3893/2015.02(02)43-051.

  12. Ríos-González CM. Adherencia al tratamiento farmacológico en hipertensos y diabéticos de una Unidad de Salud Familiar de Paraguay. Revista Cubana de Salud Pública. 2018;44(3): e1281.

  13. Franco Bonal A, Silva Valido JA, Soto Martínez O, Franco Bonal Anelys. Evaluación de adherencia terapéutica antihipertensiva en el adulto mayor. Rev. Inf. Cient. [Internet]. 2018 Dic [citado 2019 Abr 24];97( 6 ): 1124-1134. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_ arttext&pid=S1028- 99332018000601124&lng=es.

  14. Fernández-Vázquez N, García-Zurita A, Felipez- Agrelo IM, Castro Dios DJ, Remuiñán Rodríguez B. Factores relacionados en la adherencia terapéutica en pacientes a tratamiento hipertensivo. Evidentia. 2019; 16. Disponible en: http://ciberindex.com/c/ev/e10689 [acceso: 24/04/2019]

  15. Asilar RH, Gözüm S, Capik C, Morisky DE. Reliability and validity of the Turkish form of the eight item Morisky medication adherence scale in hypertensive patients. Anadolu Kardiyol Derg 2014;14:692-700. http://doi. org/b8bc

  16. Ferreras I, Fuentes JE. Intervención farmacéutica en el control de la hipertensión arterial una farmacia comunitaria Farma Journal 2016; 1(2): 117-124.




2020     |     www.medigraphic.com